Q/C Technologies, Inc. (QCLS)
| Market Cap | 5.15M-84.9% |
| Revenue (ttm) | n/a |
| Net Income | n/a-139.6% |
| EPS | n/a+98.3% |
| Shares Out | 8.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,764.206 |
| Open | 0.64 |
| Previous Close | 0.63 |
| Day's Range | 0.61 - 0.65 |
| 52-Week Range | 0.42 - 8.17 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About QCLS
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
$QCLS stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in QCLS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by QCLS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
QCLS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New QCLS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to QCLS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in QCLS
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $242.99K |
| DFASDimensional - US Small Cap ETF | $3.84K |
Estimated from each fund’s disclosed top holdings × AUM
QCLS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from QCLS’s recent data — informational, not investment advice